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INTRODUCTION
Continuous function of the central nervous
system is vitally important to the organism as a
whole and such function is very strongly dependent upon
a continuous and adequate blood supply.

Interruption

of cerebral blood flow for a few seconds leads to unconsciousness and for a few minutes may lead to irreversible changes in the brain.

Thus, the physiologic and

pharamacologic regulation of cerebral blood flm" (or CBF
as it is frequently referred to) becomes especially
important.

A discussion of the methods of study is

helpful in understanding current concepts of this
regulation.

METHODS OF S;l'UDY

Anatomical problems include the great complexity
of the anatomy of cerebral circulation and the extensive
communications between cerebral and extracerebral circUlation.

This is especially a problem in the usual

laboratory animals.
Measurement of flow to anyone of the major cerebral vessels is subject to such limitations as being
representative of an indeterminant portion of the brain
or being contaminated by extracerebral flow.

In all

animals the anastamoses with the vertebral plexus of
veins and other veins make measurement of CBF on the
venous side almost impossible.

However, this has been

done on the isolated head (1), but this could hardly be
considered physiologic.
In man the blood of the superior bulb of the internal jugular vein makes a relatively uncontaminated
and representati.ve specimen of cerebral venous blood
(2) (3).

This has allowed many of these anatomi.cal

problems to become minimized in the development of
quantitative methods for measuring CBF (4) (5) (6).
The various techniques of study must be evaluated
in the light of these anatomical problems and in their
inherent sources of error.
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A.

Direct observation of intracranial or related
vessels may utilize gross, microscopic or photographic
methods.

By inserting a cranial window (7) (8), obser-

vations can be made under more physiologic conditions.
A comparable technique more applicable to man is funduscopic examination of the retinal vessels which are
anatomical extensions of the cerebral vessels and react
similar to them in many instances (9)(10)(11).

It must

be remembered that this provides only qualitative information on the behavior of the cerebral blood vessels and
not the CBF which is also dependent upon other factors.
Observation of the superficial vessels of the brain or
retina is limited to the relatively large vessels whose
responses may differ qualitatively and quantitatively
from those of the small intracerebral arterioles which
are most important in determining CBF.

B.

Thermoelectric devices may be used to detect changes
in CBF (12)(13)(14).

The various types of thermo-

stromuhrs which permit measurement in intact vessels
are not very reliable.

However, thermocouples inserted

into the bloodstream of the otherwise intact vessel are
more satisfactory.
are used.

Both the heated and the cooled types

In the former the thermocouple is cooled and

in the latter it is warmed by the flow of blood, the
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change in temperature resulting in a change in electrical current varying proportionately to the rate of blood
flow.
A Gibbs thermoelectric flow recorder (15), i.e.
in the form of a needle, has been used for studies in
the internal jugular vein in man.

rrhis needle and its

modifications have been inserted directly into brain
tissue and have been found capable of indicating directional changes in blood flow.

Its advantages include

its simplicity, convenience, and ability to follow
continuously the change in blood flow.
include:

Disadvantages

does not provide reliable quantitative data

when used in vessels subject to the previously mentioned
anatomical li!'!itations, temperature changes in the blood
or immediate environment, clot formation around the
needle, change in vessel diameter, change in relation
of the stream of blood to the position of the needle
and inflammatory changes of the tissues.

c.

Various flow meter techniques:

There are a number

of instruments, which when inserted in series with a
vascular channel, can measure with reasonable accuracy
the rate of blood flow through that vessel (12).
This is essentially a glass tube of known cross-sectional
area, which when inserted between the severed ends of a
I

-'+-

blood vessel, permitted the measurement of the blood
flow velocity by quantitating the movement of an air
bubble trapped Hi thin it.

From the veloc i ty, the

volume of blood flow could be calculated.

By placing

the instrument in a single, isolated, common arterial
pathway to the brain after surgical occlusion of all
other possible arterial channels and anastamoses with
the extracerebral circulation, it was possible to exclude many of the anatomical problems mentioned above.
In most laboratory animals this involves very extensive
surgery and alteration of the normal physiology, but in
monkeys this method is more applicable.

D.

Artificial perfusion of the brain has been used to
study alterations in CEF (16)(17)(18).

A major advantage

of this method is in being able to control certain factors involved in blood flow, for example blood pressure,
the fluctuation of which is a frequently encountered
variable.

By perfusing at a constant arterial blood

pressure this variable can be excluded.

However, again

the disadvantages of major surgery and anesthesia required to isolate the cerebral circulation are encountered.
1i:.

The difference in oxygen

conte~ts

or saturations

between arterial and cerebral venous blood is ?irectly
proportional to the oxygen consumption and inversely
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proportional to the CBF.

'l'hus, an importmt require-

ment is that the venous blood be representative of the
brain as a whole and especially uncontaminated by blood
from extracerebral sources.

Such blood is easily ob-

tained from man from the superior bulb of the internal
~fuen

jugular vein (19)(2)(3).

cerebral metabolic rate

remains constant, a change in the arteriovenous oxygen
difference reliably indicates the direction and degree
~~en

of change in CBF.

this latter condition is fulfilled,

this method, because of its simplicity, is especially
useful in man.
F.

Because the normal adult craniovertebral cavity
is essentially a

~igid,

indistensible container com-

pletely filled with~incompressable material, any in•

t

crease in volume o:f one of i-t:c contents must be at the
"

expens~

of another.

\-,n tHis basis, Ferris has applied

the. principles of venous occlusion plethysmography to
the measurement of intracranial blood flow in man.
Unfortunately he assumed that the inflation of a cuff
around the neck to a pressure of 60 to 80 mm Eg. would
occlude the venous outflow from the cranium and thus
the rate of displacement of spinal fluid through a
needle in the lumbar subarachnoid space would equal
the rate of continued arterial blood flow into the
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cranium.

Such an assumption cannot be made, however,

This method completely ignores the numerous pathways
other than the internal jugular veins through which venous
blood may leave the

cr~~ial

cavity.

Consequently, this

method is of very little value in determining CBF.
Since its introduction by Kety and Schmidt approximately fifteen years ago (20)(6), the nitrous oxide
technique has become the standard method for studying
the cerebral blood flow.
Fick Principle (21).

This method is based on the

This principle represents a prac-

tical application of the law of conservation of matter
to

the problem of blood flow measurements.

be explained as:

This might

blood flow to any organ or to the

body as a whole may be obtained as the ratio between
the uptake of inert gas per unit time and the arteriovenous inert gas difference across the organ in question.
Kety and Schmidt applied this method to the cerebral
circulation in man.

Since then it has been applied

to various other organs and animals with similarly
satisfactory results.
The procedure may be described briefly as follows:
During a suitable period of inhalation of a constant
concentration of gas (in this example nitrous oxide),
blood samples are taken from a reripheral artery--
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assumed to be representative of the cerebral arteries-and from the main venous drainage from the brain, the
internal jugular vein.

After a suitable experimental

period, which allows approximately complete saturation
of all cerebral tissues, (frequently ten minutes), it
is possible to estimate indirectly the gas uptake per
unit weight of brain fromfue venous concentration.
Since the nitrous oxide content of the brain cannot be
determined directly, the brain nitrous oxide concentrati6n at ten minutes is estimated from the tenth minute
value of the cerebral venous nitrous oxide cnncentration
to which it is assumed to be equal.

This assumption is

based on evidence that by the tenth minute brain and
mixed cerebral venous blood have achieved approximate
equilibrium and the brainjblood partition coefficient
is normally 1.0 (22).
Since the concentration rather than the total content of nitrous oxide is employed in the calculation,
the derived values of blood flow represent the average
blood flow rate per uhi te mass of brain taken as a
and not that of the total brain.

v~hole

The unit mass of brain

used is usually 100 gram.
Because some of the basic assumptions are only
approximately correct, it becomes very important that
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the validity of the method has been clearly demonstrated by Kety and Schmidt (23)(24).

These authors

found close agreement between this method and the direct
blood flow method in experiments covering a large span
of perfusion values, i.e., 17 to 76 cC/IOOgm/min.
Since its accuracy has been accepted as being
reasonably reliable, several variations of the original
method have appeared.

For example, Scheinberg and

Stead (25) have simplified the method and reduced the
amount of blood sampling necessary, but only at the
expense of decreased accuracy.

Kennedy and his co-

workers (26) have adapted it to children by decreasing
the volume of the blood samples.

Presision has been

increased by increasing the number of blood samples,
the use of Kr85 (a Beta-emitting isotope of krypton)
and by sampling from both internal jugular veins (26)(27).
Lewis and associates, using the V-emitting Kr 79 as the
inert gas, made a more fundamental modification.

By

direct and continuous external measurement of the amount
of inert gas in the whole brain and simultaneous blood
sampling, they made it possible to calculate the total
cerebral blood flow and to follow any fairly rapid
changes in this flow (28)(29).

H.

A non-diffusible tracer substance which remains in
the circulatory system when injected into a cerebral
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artery, is diluted by the DBF in passing through the
cerebral vascular bed.

The degree of dilution, as

determined from the quantity or rate of injection of
the tracer material and again the difference in arterial
and representative cerebral venous blood was interpreted
by Gibbs et.al (14) to be a measure of CBF.

However,

as demonstrated by Shenkin eta al (3), dye when injected
into a single cerebral artery is not uniformly mixed and
thus the blood drained in one internal jugular vein is
then not representative of that of the brain as a whole.
This might be overcome by bilateral intracarotid injection or bilateral internal jugular vein sampling, or
perhaps both are required.

The end result of this

complexity is that the method is not often used.
1.

Radioactive inert gas technique for the quantitative
dertermination of regional cerebral blood flow:
As previously mentiOned, the rate of blood flow to any
given area of the brain may vary independent of that
to another area of the brain (30)(31)(32).

Only one of

the above mentioned methods provides data on the blood
flow of individual regions of the brain.

Thermocouples

inserted in the various area of the brain may indicate
local changes in blood flow, but they are subject to
numerous limitations and yeild only qualitative infor-
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mation rather than quantitative.
A method has been described by Kety and his associates which measures simultaneously and quantitatively
the blood flow in as many as twenty-eight structures
of the brain (33)(30)(31).

The method is basedm the

principle that the uptake of an inert radioactive gas
by a tissue is a function of the preceding history of
the arterial concentration of the gas, the partition
coefficient of the gas between the tissue and blood,
the time, and the blood flOIr? of that tissue.

During

intravenous infusion of a solution of the radioactive
gas, arterial concentration is continuously monitored
by a scintillation counter.

Then, at a specific recorded

time the head is removed, frozen and the concentrations
of the gas in the various cerebral structures are determined by a radioautographic technique.

Thus with these

data, using the measured solubilities of the gas in
blood and brain tissue, the blood flow in the various
areas can be calculated.

This method gives reliable

results but obviously is useful only on laboratory
animals (30) (31)(32).
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NomlAL REGULATION OF THE CEREBRAL CIRCULATION

There are numerous

revie~

of the physiology of

the cerebral circulation (34)(35)(36)(37)(38)(13)(39).
Drugs usually alter the cerebral circulation by influencing the physiological mechanisms normally regulating
it.

It should be remembered that the brain is the organ

which receives highest priority in the body's effort to
preserve its most vital organs from circulatory
insufficiency.

In order to accomplish this, the regula-

tion of the CBF must be unique.
As in all vascular beds, the blood flo\<! is ultimately
determined by two major hemodynamic factors:

(1) the net

pressure gradient across the vascular bed, (2) the total
resistance to blood flow in the vascular channels.
These two factors, in turn, are determined by the numerous forces that alter, regulate or contribute to them.
It is by altering one or both of these major factors
that physiologic and/or pharmacologic changes in the
CBF are accomplished.

A.

Cerebral blood pressure gradient:
Cerebral venous pressure is very low in relation
to usual cerebral arterial pressure and is therefore
gen~rally

CBF.

of very little

i~portance

in determining

However, in instances where it is greatly
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altered, it may assume a more significant role.
For example, a marked fall in cerebral venous
pressure may be an important mechanism in maintenance of CBF under gravitational stress (40).
Likewise, a marked elevation of cerebral venous
pressure might also be expected to influence CBF.
However, this has not been clearly demonstrated (41).
Huch more important in determining CBF is the
mean arterial blood pressure.

Earlier it was assumed

that the CBF passively followed the mean arterial
pressure (42)(13)(39).

Later studies carried out

in man showed that intrinsic regulation of the
cerebral vascular resistance also occurs.

This

tends to keep the CBF within Certain normal limjts
despite changeS in blood pressure and may alter it
indepentent of blood pressure.

Fog (43) had earlier

reported that pial vessels of animals under direct
observation constricted in response to an increase
in arterial blood pressure and dilated in response
to a fall in arterial blood pressure.

Likewise, in

man the CBF does not increase in essential or
drug-induced hypertension (44)(45)(46)(47) because
of this increase in cerebral vascular resistance
in these instances.

Also consistant with Fog's
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observation is the finding that cerebral vascular
resistance also buffered the

eff~cts

of arterial

hypotension (48)(49)(50).
In normotensive subjects it was also found
that reducing the mean arterial blood pressure to
approximately 30 mm Hg., or one-third the normal
level resulted in clinical signs and symptoms of
cerebral ischemia. (51).

This was accomplished by

use of hexamethonium and/or tilting the subjects.
It was also noted that subjects with malignant
hypertension or p6stural hypotension did not reduce their cerebral vascular resistance as effectively
and thus developed signs and symptoms of cerebral
ischemia with a smaller decrease in me5n arterial
blood pressure.

In all cases the evidence of

cerebral ischemia appeared when the CBF fell to a
mean of 31.5 ml per 100 grams per minute.

This is

approximetely sixty percent of the control level.
It is also postulated (52) that in secondary shock
and other hypotensive states resulting in unconsciousness that the mean arterial blood pressure
falls below the limits of compensation by changes
in cerebral vascular resistance.
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B.

Cerebral vascular resistance:
Under physiological conditions CBF is regulated
chiefly by changes in the cerebral vascular resistance.

For quantitative determinations this is

defined as the ratio of cerebral blood pressure
gradient to blood flow.(6).

Actually it is made

up of a number of factors which tend to impede the

flow of blood through the cerebral vessels.

These

factors will be discussed individually below:
1. Blood viscosity:
Blood viscosity varies mainly with red blood
cell concentration but also with marked changes
in the plasma protiens or other cell
tj_ons.

concentra~

An increase in RBC concentration leads to

an increase in resistance and a decreased

concen~

tration to a decreased resistance to flow.

The

increase in resistance becomes more marked as the
upper limits of normal red cell concentration
are exceeded (53).

Thus in polycythemia vera we

see anextremely low cerebral blood flow and
a high cerebrovascular resistance (35).

Likewise

there is an increased CBF seen with anemia (54)(55).
2. Intracranial pressure:

The cerebral vessels are partially exposed
to the direct pressure of the cerebrospinal fluid.

-15-

As the cerebrospinal pressure increases, one
would expect the size of the vessel lumen to
decrease and fuus the resistance to blood flow
to increase.

Likewise, as the cerebrospinal

fluid pressure decreases, one might expect to
see a certain amount of expansion of the blood
vessel wall and an increase in blood flow.
Observations made to date do not seem to be so
clear-cut (56)(57)(58)(59).

However, observations

made on normal subjects would seem to indicate
that a reduction in intracranial pressure, as
occurs on assupmtion of the erect position (25)
or under the influence of positive radial
acceleration (60), tends to increase the CBF
by lowering the cerebrovascular resistance.
Because most of the inconsistant observations and
reports were not made on normal subjects, this
author tends to give them less emphasis.

3.

Size and tone of cerebral vessels:
It is largely through the adjustment of
the diameter or tone of the cerebral ves2els and
the consequent altsration of cerebrovascular
resistance that the normal regulation and remarkable hemeostasis of the cerebral circulation
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is accomplished.

It is also through their effect

on the cerebrovascular tone that most drugs and
diseases cause their alteration in the CBF.
Anatotlical nar owing of the vessel lumen and
therefore increased resistance are seen in the
two most comm0n vascular diseases:

arteriosclerosis

and hypertension (61)(11)(62)(63)(64).
Alterations in CBF may be brought

~bout

by

(1) direct changes in the vessels themselves
as above or (2) by alterations of some of the
following control mechanisms of the cerebrovascular tone:
a.

Neurogenic control:
Because of the minute size and great number of vessels and nerve pathways and many
other technical difficulties involved, this
area of study is very difficult.

It would

seem to this author that the following conelusions may be valid:

(1) Neural vasomotor

mechanisms in the cerebral vasculature do
exist but their role in the resulation of
cerebrovascular tone is not obvious at this
time.

(2) Evidence seems to suggest that

there is no resting neurogenic vasoconstriction

-17-

tone mediated through the cervical synpathetics.

(3) It also seems unlikely that there is any
resting neural vasodilator tone.

(4) The

cerebral vasomotor reflexes are not integrated
into the general circulatory reflexes such as
those from the carotid and aortic pressoreceptors.

(5)

When neurogenic vasomotor effects

are demonstrated, they are of small magnitude.
These conclusions were suggested by the following works,

(65)(66)(67)(66)(68)(69)(70)(14)(71)

(72)(39)(73)(74)(75)(76)(77), and do not seem
to be of major importance.
b. Chemical control:
The only major changes in CBF that have
been experimentally induced are those caused by
chemicals.

The endogenous chemicals that are

most prominently involved in the normal regulation of cerebrovascular tone will be considered
at this time.
The respiratory gasses, i.e. oxygen and
carbon dioxide, are the most potent agents of
this type.

An increase in the blood carbon

dioxide causes a marked vasodilatation and
increase in the CBF, as if to get rid of the
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excess waste product.

A decreased blood car-

bon dioxide level, as in hyperventilation, causes
a vasoconstriction and a decrease in CBF

An increase in blood oxygen concentration
causes a vasoconstriction and a decrease in CBF.
A decrease in blood oxygen concentration causes
a vasodilatation and thus an increased CBF
tending to compensate for the oxygen lack.

(78)(79)(80) .
Thus in general we have carbon dioxide
acting as a vasodilator and oxygen acting as

a

vasoconstrictor.

1~en

the forces of the two

are opposing one another at usual physiologic
concentrations, carbon dioxide seems to be the
stronger of the two (35)(13)(39).

However,

if the hypoxemia is greet enough, it will overcome the vasoconstrictor effect of low carbon
dioxide (81)(78)(82).
Acids and bases have been reported to
cause

cerebral vasodilatation and vasoconstric-

tion, respectively (17)(13)(39)(8).

Despite

the markedly lowered blood carbon dioxide which
occurs in diabetic coma, there is a reduced

-19-

cerebrovascular resistance and increased CBF.
This would suggest that the severe acidosis
existing in this condition might have more
influence on the cerebral vessels than the
reduced carbon dioxide.

Thus while in usual

physiologic ranges we find carbon dioxide a
more potent agent than changes in pH or oxygen
concentratjon, when the latter two are far
enough from the normal range, especially when
they are attempting to dilate vessels, they
become more potent.
These observations can be integrated if
one notes that the normal chemical products or
consequences of increased tissue metabolism,
for exafuple, increased carbon dioxide, reduced
oxygen, and alse,.. perhaps, lOv-Jered pH, tend to
produce cerebral vasodilatation; and since
changes in the opposite direction which would
accompany decreased cerebral metabolic activity
cause vasoconstriction, it has been suggested
that CBF may be adjusted via such ch2mical means
to local metabolic activity.
This mechanism would tend to maintain chemical hemeostasis which is what is required and
-20-

observed in most physiologic regulatory systems (83)(olJ\.84)(13)(14).

That such a

homeostasis mechanism exists is supported by
the good correlations between the levels of
CBF and oxygen consumption in man (35) and
in the monkey

(85), and by the parallel in-

crease in both during metrozol convulsions in
the monkey (85).

Other findings supporting

this theory are close correlations between
CBF and cerebral activity seen in the rabbit

(86) and cat (87)(88).
In man, 101.<; metabolic rates and low CBF
have been observed in various pathological
states of depressed mental function (35),
but normal variations of mental activity,
for example, normal sleep (89) or performance
of mental arithmetic (90) seem to produce no
detectable change in CBF.

It should be empha-

sized that this does not mean that such changes
do not take place.

One explanation might be

that these changes are too subtle to be detected with present methods and equipment.
Another explanation might be that such changes
take place only locally in the specific area of
-21-

of the brain that is involved in the greater
activity while the rest of the brain has a
decreased rate of metabolism and oxygen consumption, thus giving no net change in

o~Jgen

consumption and CBF as measured for the whole
brain by most methods.
Then to the first theory of CBF regulation
locally by metabolic chemicals, we add secondly
that the mean arterial blood pressure tends to
be maintained constant at the brain because of
nervous vasomotor reflexes of the baroreceptor
type.

The cerebral vessels seem to be

indepen~

dent of these neural vasomotor mechanisms.

It

is this independence which allows the blood
flow to the brain to be maintained in certain
ciEcumstances at the expense of other tissues.
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THE EFFEcrl'S OF DRUGS ON 1'HE CEREBRAL CIRCULATION

In spite of the remarkable ability of the CBF to
maintain hemeostasis, its limits of compensation naturally can be exceeded.

In such instances it may be

desireable to administer drugs in an effort to restore
the abnormal CEF to within normal limits.

A brief dis-

cussion of the many drugs used for this purpose follows.
In this discussion these drugs will be grouped as they
usually are in pharmacology rather than by any system
regarding only their use for the effect on the cEF.
In deciding how much time to devote to each drug the
factors considered were:
prac~ic2

its importance in the general

of medicine today, its usefulness in altering

CEF, and finally how much research has been

d~ne

on the

effects of this drug on the CEF.
A.

The respiratory gases are given further consideration:
1. Carbon dioxide:

The effects of hyperventilation betray the
fact that the carbon dioxide normally present in
blood exerts a continuously tonic vasodilator
action on the cerebral vessels (91)(92)(4)

The mechanism or method by which carbon
dioxide alters the tone of the cerebral vessels
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is not known for certain but two suggestions
are offered.

One is that it is a local axon

reflex which has not been demonstrated thus far.
A more likely explanation is that it is the direct
action of carbon dioxide upon the smooth muscle
of the vessel wall as it diffuses through this
wall from the surrounding tissues.

One might

consicLer the finding that oxygen diffuses through
the walls of relatively large pial veins to be in
support of this theory (39)(96).
Some of the quantitative studies of the
effects of carbon dioxide are as follows:
Kety and Schmidt originally noted that the CBF
of young and old subjects alike increased approximately seventy-five percent during the inhalation
of five to seven percent carbon dioxide (78)(E2)(91).
~hat

may be more exact observations report that

inhalation of five percent carbon dioxide increases
CBF approximately fifty percent (78)(97)(64),
whereas inhalation of seven percent carbon dioxide,
the concentration with approximately maximal effects
on pulmonary ventilation and blood pressure (98),
more than doubles the blood flow (78)(99)(95)

(97)(64).

One cannot say whether seven percent

also produces maximal cerebral circulatory changes
because reliable oomparable data from man with
higher concentrations is not available.
Regarding lower concentrations, it was found
that inhalation of two and one-half percent carbon
dioxide does not alter the CBF.
CO

2

However,

3.5%

produced a slight but significant increase in

CBF of ten percent (97).
Quantitative studies of hypocapnea in man

(91)(92)(4)(94)(78)(99)(95) show a greater
degree of cerebral vasoconstriction than has been
obtained by any other method, i.e. 60% of the
control flow achieved by lowering blood carbon
dioxide from 45 to 26 mm mercury by active or
passive hyperventilation.

This low level of CBF

approaches that at which syncope occurs (51) as
expected evidence of cerebral ischemia was present.
The response of the CBF to alterations of arterial
carbon dioxide were prompt, almost immediate, the
latency obtained is largely attributable to the
inaccuracies of the technique (99)(95).
The threshold of the cerebral circulatory
response to increased carbon dioxide concentrations
in the inspired air is reduced when combined with
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low blood oxygen concentration (100)(97), i.e.,
the CBF which is already increased by hypoxemia
is percentage-wise less increased by an increase
in inspired carbon dioxide than it normally is by
carbon dioxide alone.

Apparently the cerebral

vasodilatation already produced by hypoxemia
(74)(61)(10)(78)(102)(13)(39)(8) represents
a con tributary part of that which would result from
a raised carbon dioxide tension alone and tends to
combat the vasoconstriction effect of a reduced
carbon dioxide tension.

One might even carry this

further and expect to find the exact point of
lowered oxygen tension at which the effects of
carbon dioxide are negligible.

This point, of

course, must be exceeded if we are to reach the
point where the oxygen concentration becomes far
enough from the physio16gic range that the vasodilatation power of hypoxemia exeeds the constrictive power of hypocapnea.

Quantitative

studies in the dog by Noell and Schnei er (82)
indeed show that this point is at a cerebral venous
oxygen tension of approximately nineteen mm. mercury.
Observation of similar phenomenon in man is also
reported (81).
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In the clinical conditions of resporatory
arrest (103) or rebreathill.g (101) in which again
combined hypoxemia and hypercapnea are encountered,
this action allows at least a temporary protective
mechanism for the central nervous system.

In

these instances the administration of additional
carbon dioxide with the intention of improving
cerebral circulation would

~robably

be of very

little help and indeed raises the immediate danger of increasing the carbon dioxide level to a
depressant level.

It has been difinitely shown

that carbon dioxide becomes less

~fective

as its

blood tension deviates further from the normal
physiologic range (82).

However, in conditions

of hypoxemia not complicated by carbon dioxide
retention, but rather by hypocapnea secondary to
hyperventilation, the administration of carbon
dioxide provides

effective aid against the cere-

bral effects of oxygen lack (101).
The action of carbon dioxide on the cerebral
circulation is altered very little, if at all, by
elevated blood oxygen tensions (104).

This illus-

trates what a relatively weak cerebral vasoconstrictor hyperoxemia is (54)(105)(78)(79)(102)
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(106)(80)(8).

Thus the combination of high

oxygen ahd high carbon dioxide concentrations in
inspired air which is so frequently employed
clinically is a very helpful combination, i.e.,
the patient receives

a~most

the same degree of

augmentation of the CBF as with pure carbon dioxide---plus the higher oxygen concentration.
As mentioned previously, acidosis causes
cerebral vasodilatation (17)(107)(13)(39)(8),
and when severe enough, this acidosis may override
the effect of a reduced blood carbon dioxide in
diabetic coma (108).

On the other hand, in meta-

bolic alkalosis the cerebral vascular responses
to carbon dioxide are not decreased (109).
The~e

is much speculation concerning the loss

of vascular wall elasticity associated with advancing a~e (61)(91)(110)(63)(64) and/or cerebral
vascular disease (61)(91)(110)(62)(64).
Schieve and Wilson (64) came to the conclusions
that cerebral vascular reactivity to the inhalation
of five and seven percent carbon dioxide decreases
gradually with age, falls markedly with cerebral
vascular disease and that it could be used clinically to distinguish between senile dementia
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arising from

pr~mary

brain degeneration and that

secondary to cerebral vascular disease.

However,

further investigation has tended to indicate that
although the degree of reactivity is somewhat reduced, especially when the disease is organic and
associated with old age, this change in reactivity
does not appear to be sufficiently pronounced or
uniform enough to be used as a reliable test for
organic cerebrovascular disease. (91)(78)(63)
Study has also been make on the effect of
carbon dioxide on local cerebral circulation (72)
(111)(70)(14)(71).

Kety and associates (33)

(30)(31) show that blood flow to all parts of
the brain is increased by carbon dioxide, but the
increases were not uniform (112).

The changes

were absolutely and relatively greater in gray
matter than in white.
As for the mechanism of action of carbon
dioxide on the CBF, it seems to be almost entirely
through its effect on cerebrovascular resistance
(61)(91)(78)(62)(97).

Of the various pre-

viously mentioned factors which determjne resistance, only two are greatly altered.

First, the

cerebrovascular tone is marke'ly decreased by
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carbon dioxide.

Active dilatation of the pial

vessels has been directly visualized "Ii thout any
associated drop in arterial blood pressure (113)

(8), thus the resultant increase in CBF.

The

second factor which is altered, namely the intracranial pressure, is increase by the vasodilatation
and resultant increased blood volume, content and
flow to the brain (114)(115)(116)(9)(117).

This

increase in intracranial pressure would tend to
increase rather than lower cerebrovascular resistance, but its effect is a minor one.

The mechan-

ism of this dilatation is probably by direct action
of carbon dioxide on the smooth muscle of vessel
walls (39)(96) as mentioned earlier.
The increase in CBF caused by increased carbon dioxide is associated with an increase in the
mean arterial blood pressure of man and laboratory
animals (61)(78)(62)(98)(118)(74)(111).

This

would also contribute to the rise in CBF but this
does not seem to be responsible for most of this
increase (91)(78)(39).

This increase arterial

blood pressure is due to a stimulation of the vasomotor center by carbon dioxide and a resultant
vasoconstriction in the extranial circulation.

-30-

_ _ _. __

There is no increase in cardiac output.

~.-.i!Ii("

.~_~

_______________

The cor-

onary circulation does not appear to be affected
by carbon dioxide (14)(119)(103)(120)(102)(121)
(122)(123)(14)(124)(78)(123)(125).

A reduction

in blood carbon dioxide concentration causes the
opposite effect (119)(120)(102)(121).
Useful applications of the effects of carbon
dioxide might include:
(a)

It is useful to aid recovery from general

anesthesia because it stimulates pulmonary ventilation, thus increasing the rate of elimination of
volatile anesthetics, and because of the greater CBF
there is a faster removal of the anesthetic agent
from the central nervous system.
(b)

In circulatory collapse or secondary shock

carbon dioxide may be useful.

By dilating cerebral

vessels and constricting the extracranial vascular
bed, except for the coronary vessels,

(125), the

cardiac output is redistributed to favor the brain
at the expense of less vital tissues (119)(103)(120)
(l02)(121)(123){14)(124).

It might also counteract

the hypocapnea secondary to the hyperventilation
frequently associated with these conditions and
thus prevent the expected cerebrovascular constriction.
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_

(c)

It is probably because of the above mentioned

redistribution of cardiac output that it gives a
greater tolerance to positive radial acceleration
and thus delays the loss of consciousness (126)
( 127 )( 128 ) •
(d)

Carbon di~xide has been reported to inhibit

petit mal seizures (129), but is should be noted
that the etiology of these seizures does not involve the cerebral circulation (130) (93).

The

mechanism of action in this example is probably
related to the effects of carbon dioxide on the
electrical activity of the brain which will be
discussed below.
(e)

(81)(121)

The therapeutic use of carbon dioxide in

chronic cerebral vascular insufficiency is questionable.

Three percent carbon dioxide is useful

in counteractin the mental effects of anoxemia
(131) and the increased cerebral venous oxygen
saturation is secondary to the augmentation of
the CBF by carbon dioxide.

However, the improve-

ment in the mental and electrical activities cannot entirely be attributed to better oxygenation
~f

the brain.

Gibbs reported mental and electro-

encephalogr~phic

abnormalities in subjects
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inspiring gas mixtures free of carbon dioxide and
low in oxygen concentration when the cerebr2-1
venous oxygen concentration was at a level during
which these functions had been normal when the
subjects were breathing carbon dioxide-enriched
low oxygen mixtures (101).

It is felt that the

anoxemia and its secondary hyperventilation lowered
the carbon dioxide concentration of the blood and
brain below the optimum concentration of carbon
dioxide which is necessary to maintain normal
cortical electrical activity and mental function
(81)(121).
2. Oxygen:

Quantitative studies demonstrate that the
vasoconstrictive effects of higher cerebral arterial oxygen concentration are less potent than the
vasodilatation caused by hypoxemia.

The breathing

of eighty-five to one hundred percent oxygen concentration causes only a mild decrease in CBF of
approximately twelve to fifteen percent (54)(78)

(79).

At onc atmosphere breathing, fifty or

eighty IJercent oxygen concentration has a negligible
effect on CBF.

In contrast, reducing the arterial

oxygen concentration by breathing ten percent
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oxygen causes an increase in the CBF of almost
fifty percent and a marked decrease in cerebrovascular resistance (78).

This homeostatic type

of response by the cerebral vasculature to hypoxemia allows a greater decrease in the arterial
oxygen concentration before the critical concentration is reached in the tissue and venous blood.
'l'his is illustrated by the fact that the oxygen
concentration of internal jugular venous blood,
which reflects the concentration of cerebral
tissue, falls more slowly than arterial oxygen
concentration upon ::he inhalation of low oxygen
mixtures (121).
The approximate critical range of cerebral
venous oxygen concentration below which consciousness is lost is between twenty-four and thirty
percent (132).

This corresponds to an oxygen

tension of approximately fifteen to twenty mm Hg.
There is no detectable 6hange in cerebral oxygen
consumption as the subject becomes unconscious (78).
This

h~,lds

true for oxygen concen tra tions as low

a6 eight and ten percent (80).

This does not

necessarily mean that they do not exist, as these
changes may be too subtle for present methods to
detect.

-Y+-

The

chan~es

in cerebral circulation caused

by hypoxemia are not uniform for all areas of the
brain (1120(133).
matter, which is

The circulation to the gray
genera~ly

greater than that of

white matter, has a greater absolute and relative
increase.

The alterations are not even uniform

for all areD.S of gray matter.
It has been suggested that the mental changes
of hypoxemia may be due to the reflex hyperpnea and
hypocapnea, i.e.
for the mental

the same mechanism responsible

sy~ptoms

seen without lowered cere-

bral oxygen utilization during hypocapnea produced
by hyperventilation (78).

It is interesting that

at approximately the same critically low level of
cerebral venous oxygen both consciousness and the
normal electroencephalographic pattern are lost
( 132 )( 121) .
The mechanism by which oxygen concentration
causes its effect on cerebral vessels is

ot very

well understood at this time.
Genen~lized

convulsions are frequently seen

during prolonged inhalation of oxygen at pressures
greater than one atmosphere (134)(135).

Because

changes in CBF and carbon dioxide retention.
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secondary to oxygen saturation of venous blood
"'"
.
have been excluded as etiological .lact:ors,
it is

suggested that there may be acirect toxic
effect of high oxygen tensions on the enzyme systems of the central nervous system (134)(135)(79).
When premature infa.nts are subjected to prolonged periods of high oxygen concentration
tion,

a~enomemon

inhala-

called retrolental fibroplasia

takes place (136)(137).

The high oxygen tension

apparently allows obliteration of part of the vascular bed which is needed when the oxygen concentration of the blood is allowed to return to normal.
The administration of oxygen to patients with
chronic pulmonary disease is well known as a source
of problems (106)(138)(139)(140)(141).

The para-

doxical response frequently seen here is the apnea
caused as oxygen administration removes the hypoxic
stimulation of a respiratory center no longer sensitive to change in the

markedly abnormal carbon

dioxide concentration.

3. Miscellaneous agents which alter respiratory gas
transport qr function:
a.

Acetazoleamide (Diamox) if given in large enough

do

doses to inhibit nearly all carbonic anhydrase
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activity (i.e., 10-50 mg/Kg.)

results in an

increase in CBF which persists over an hour
after injection (142).

Although

~he

arterial

carbon dioxide content is decreased by the
hyperventilation, there is an increase in the
venous and tissue carbon dioxide concentrations
because of the carbonic anhydrase inhibition.
b. Carbon monoxide interferes with blood transfer

of oxygen and thus produces vascular changes
similar to hypoxemia.

Breathing concentrations

as low as 0.2 to 0.3% cause up to forty to
eighty percent dilatation of pial arteries (143).
c. The increased volume of the brain subsequent to

cyanide adminstration suggests cerebral vasodilatation.

Its cytotoxic anoxic mechanism

causes changes similar to those of hypoxemic
anoxia

B.

(lL~4).

Acids, Alkalis, Electrolytes, Inorganic Ions and Fluids:
Acids and alkalis have been discussed previously
and their effect is not especially impressive.

However,

certain electrolytes, inorganic ions and fluid agents
cause their effect because they are acids or alkalis.
It has been suggested that the potassium ion may be
a cerebral vasodilator (13)(85).
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Calcium ion is

reported to have no effect (121).

Barium ion, as

five percent barium chloride, is a potent vasoconstrictor of all vessels.

However, lower concentrations

have very little effect (145).
In general, it does not appear that these agents
cause much effect on CBF.

The major exception being

the decrease in cerebrospinal fluid seen after administration of hypertonic solutions, urea, or after
diuresis.

The major mechanism operating is the de-

crease in cerebrospinal fluid pressure and the secondary decrease in cerebrovascular resistance.

There

is also some alteration in the cerebral hemodynamics
due to the change in blood viscosity.
C.

Drugs acting on the central nervous system:
1.

Central nervous system depressants:
a.

General anesthetics:

~hen

administered to the

point of respiratory depression, all anesthetic
agents cause cerebral vasodilatation and increased blood flow secondary to hypoxia and
carbon dioxide retention.
The nitrous oxide method can only be used
in the presence of volatile agents if the radioactive krypton modification (146)(99)(95)(147)
is employed because of the interference in blood
nitrous oxide determinations.
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Diethyl ether has repeatedly been demonstrated to have a specific cerebrovascular
dilating effect, (148)(149)C150)(39)(115)(114)
(14)(72)(71), and an extracrania1 vasoconstriction similar to carbon dioxide.

Then when

the medullary centers become depressed, the
extracranial vasoconstriction relaxes.

The CBF,

h01tJever , continues to be augmented.
Most

experiment~

evidence seems to suggest

that in general volatile anesthetics tend to
dilate cerebral blood vessels.
(149)(152)(151)(113)(153)(43)

(13)(14)(39)
It must be rem-

embered that much of the information available,
especially that obtained from animals, was obtained while the subject was under some type
of anesthesia.
Many reports of the effects of barbituates
on CBF are available and they can be taken to
be somewhat representative of the general anesthetics.

The one exception is ether.

Any major

effect that these agents do have is probable
secondary to their effects on blood pressure,
cerebral metabolic rate, and the respiratory
gas tensions of the blood.
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The one effect demonstrated to be due to
the barbituate is decreased metabolism rate and
thus decreased oxygen requirement (154)(155)(156)
(157)(64)(158)(159)(115).

Because of the chem-

ical regulatory mechanisms described earlier,
there is then a decreased cerebral blood flow.
The greatest reduction of blood flow takes place
in the primary sensory areas of the cerebral
cortex.

Thus the net result is that the differ-

ences in blood flow among the various cortical
areas, so prominent during consciousness, are
eliminated (30)(31).
b.

Local anesthetics:

No effect could be demon-

strated by systemic administration of 750 mgm
porcaine or novocaine to normal subjects (160).
However, there have been reports of rapid clearing of neurological abnormalities secondary to
cerebral gas embolism after the intravenous
administration of procaine(161).
c.

Narcotics:
direct

These drugs cause no significant

~ffect

on CBF.

Their effects when they

do occur are due to influence on respiratory rate
and the secondary carbon dioxide retention.

The

resultant cerebrovascular dilatation is probably
responsible for the increase in cerebrospinal
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fluid pressure seen with these drugs (115).
d.

Ethyl alcohol:

Venous concentrations of

200 mgm% have no effect on cerebral metabolic
rate, vascular resistance or blood flow (162)
(163)(164)(165).

ll'lith higher concentrations,

an increase in CBF has been demonstrated, but
whether alcohol is directly responsible is yet
to be proven (162)(163).
Methyl alcohol, however, causes a decrease
in both cerebral blood flow and metabclicrate
(163)(166).
e. Hypnotics, sedatives, analgesics and anti-

convulsants:

With one exception, there haa been

no significant effect demonstrated by these
~gents.

Unlike adults, it has been reported that

cerebral blood flow was significantly reduced
~

epileptic children.

with

d~phenylhydantoin

normal.

Effective therapy
restored these values to

The mechanis~ is not understood (167)

(92 )(93).
2.

Central nervous system excitants:
a.

Convulsant drugs:

Only with large enough doses

of these drugs to cause convulsions is the cBF
and oxygen consumption increased.

Following the

seizure the CEF, metabolic rate, and functional
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activity were markedly reduced.

When no con-.

vulsion occurred, the same or even larger dosage failed to produce an increas in the CBF
(74)(85).

Thus the alteration in CBF is due

to the same chemical phenomenon that normally
accompanies changes in metabolic rate (168)(88).
However, the compensation that occurs is inadequate and cerebral oxygen concentration may
fall to remarkably low levels during convulsions (35)(168).

Thus the therapeutic use of

analeptic drugs to stimulate a depressed nervous
system can be hazardous.
b.

Xanthines:

Intravenous admjnstration of ther-

apeutic doses of caffeine sodium benzoate,
theophylline and aminophylline has been shown
to cause a decrease in CBF of up to twenty-five
percent (169)(170).

This effect has been em-

ployed successfully to treat hypertensive headaches (171).

The conclusion was made that this

was due to relief of vascular distention.
Moyer and co-workers (172) have come to
the conclusion that these drugs arrest CheyneStokes respiration by direct stimulation of the
respiratory center.

However, alternatives in-

clude such suggestions as relative ischemia,
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anoxia and/or carbon dioxide accumulation in
the respiratory center.

3.

Psychotropic drugs:

(There are so many new drugs

of this type that only a representative few will
be mentioned)
a.

Psychotomimetic drugs:
Mescaline, a drug

which~oduces

psychic

aberrations and visual hallucinations was shown
to increase CBF and metabolic rate (173)(174)

D-lysergic acid (LSD-25), a partially
synthesized derivative of ergot, produces similar effects in extremely minute doses (176)
(177)(178).

Studies on man failed to reveal

detectable changes in CBF or metatolism.

How-

ever, doses twenty times those used in man caused
an increase in CBF ±n the isolated ~at head (179).
b.

Psychotherapeutic drugs:
In this group of drugs there has been no
demonstration of change in metabolic rate or CBF.
Summarizing the psychotropic drugs

B.S

a

group, it would seem that their psychological
and mental changes are to some extent similar
to those of the barbituates OF of schizophrenia,
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i.e., without any change in cerebral metabolic rate or blood flow that can be detected
by present methods.
D.

Autonomic Drugs:
1.

Sympathomimetic Drugs:
a.

Epinephrine:

Less than pressor does of epin-

ephrine have little or no effect on cerebral
circulation and metabolism (46).

However, when

pressor doses are used, the CBF increases in
proportion to the rise in blood pressure because
the cerebrovascular resistance remains unchanged

(169)(45).

The expected vasoconstriction re-

sponse to the blood pressure increase is probably neutralized by the increased metabolic rate
and its associated vasocilatatory influence (43)(45).
b.

L-Norepinephrine (Levophed):

In the normal state

the vasoconstriction influence of. this drug is
neutralized to some extent by the pressoreceptor
reflexes (180)(45)(46).

Because the cerebral

vessels are not under the influence of these
reflexes, they are constricted more than the
rest

cr

the vascular bed (13)(39).

The result

is a decrease in CBF while the metabolic rate
remains Unchanged.
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In hypotension due to secondary shock
the mechanism is less understood but it causes
an increase in blood flow and oxygen tension
in the brain (18).

Some of this effect is due

to the rise in cardiac output produced by this
drug in certain stages of hemorrhagic shock (182)
(181)(183).

c.

Aramine:

d.Wyamine:
e.

Acts like L-Norepinephrine (184).
Actions resemble Epinephrine (185).

Amphetamine:

This drug causes an increase in

blood pressure but does not alter CBF or cerebral metabolic rate.
2.

Parasympathomimetic Drugs:
Although the cerebral circulation is without
any significant parasympathetic nervous control,
the choline esters are capable of dilating cerebral vessels as they do other vascular beds, but
their effect apparently is only transiet in nature
and of minimal importance (74)(111)(14)(13)(85).
Because this vasodilatation results from their
direct action and is not a simpJe response to the
associated hypotension they cause, there is an
actual increase in CBF.

Pilocarpine and the cholin-

esterase inhibitors do not seem to cause any
-45-

important change either (13)(14)(85).

Their

greatest influence on the CBF is secondary to
their systemic effects, especially those on
the mean arterial blood pressure.

3.

Autonomic Blocking Agents:
a.

Adrenergic blocking agents:

The natural ergot

alkaloids exert no consistant action on the cerebral vessels.

They may dilate in small doses

and constrict in larfe doses, but CBF usually
follows the change in systemic blood pressure
and cerebral metabolic rate is unchanged (85)(74).
The findings of vfolff ana his associa [-es suggest
that migraine headache results from the distention of the branches of the external carotid
artery which are all extracerebral in man.

They

feel that ergotamine relieves the headache by
constricting them and reducing the pulsations
within them (186).
The dihydrogenated ergot alkaloids cause
a cerebrovascular relaxation but this is prob,
ably a non-specific response to the hypotension
they produce and is probably mediated by the
chemical mechanisms of cerebral herr@©stasis
(187)(188)(189)(190)(191)(28)(49)(50).
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It is unlikely that the imidazoline
derivatives have any significant effect on the
cerebral circulation (192)(193)(194).
Dibenzyline produces its effect only by
its influence on the arterial blood pressure (195)(190).
b.

Drugs which block post-ganglionic cholinergic
nervous function show no reliable evidence that
they have a significant influence on CBF.

c.

Ganglionic blocking agents exert their effect
only by the hypotension they produce (196).

d.

Nicotine and related drugs cause in increase in
cerebral metabolic rate and CBF up to 30% when
large enough doses were used (197).

This may

be due to stimulation of the carotid and aortic
chemoreceptors (198), the release of epinephrine

(198), or to direct stir:mlation of the central
nervous system.
~.

Miscellaneous Vasodilatory Drugs:
This group has in common the ability to produce
anteriolar and/or capillary dilatation of the cerebral
and extracerebral circulation by direct action on the
vessel walls.
1.

Histomine causes cerebral vasodilatation in men and
animals but because of its secondary hypotension
-47-

caused by a similar systemic effect, it does not
always increase CBF (1 1+) (199) (169).

Because its

action is of transient nature, it is of little value
in therapy of cerebrovascular insufficiency.
2.

Nitrites cause a marked but transient cerebral vasodilatation and increased CBF (74)(169)(111).
~rolonged

With

administration the hypotension finally

overcomes the cerebral vasodilatation and CBF is
decreased (Ill).

3.

Papaverine does not cause much change in the CBF
because again there is an associated hypotension

\ 200 ) (201) (202) .

4.

Nicotinic acid has no significant effect on CBF,
vascular resistance or oxygen consumption (203)(204).

F.

Miscellaneous Antihypertensive Drugs:
Included in this group are (1) the rauwolfia
alkaloids,

(2) veratrum alkaloids, and (3) hydralozine.

These drugs fail to produce any direct effect on the
CBF and their only influence is by decreasing the
systemic blood pressure (205)(206)(207)(208)(209).
G.

Hormones and Related Drugs:
1.

Thyroid Hormone:

The cerebral circulatory changes

associated with altered thyroid function parallel
those occuring in cardiac output (210)(211) and

in blood flow to most other organs and tissues.
However,

the metabolic rate of the brain is un-

changed so this cannot be used to explain these
changes.

There is no evidence of a direct action

on CBF by thyroid hormone but there is also no
other explanation (212)(210)(213)(214)(215)(216).
2.

Insulin:

Insulin administration even in dosage

adequate to produce coma and depress the cerebral
metabolic rate have no effect on the CBF (217).
Insulin deficiency, however, may produce changes
but these are dependent on the disturbances in
acid-base balance or carbon dioxide tension.

3. The adrenal medullary hormones have been discussed
previously.

4. AC'I'H ahd the adrenocortical steroids:

Prolonged

daily administration of these drugs increases mean
arterial blood pressure and cerebrovascular resistance proportionately, and no change in CBF or
cerebral metabolic rate was detected.

W'hen the

drugs were discontinued the functions returned to
normal (218)(219).

5; Gonadal steroids and related compounds have no
clearly understood role in regulation of CBF.

6. The anterior pituitary hormones

li~ewise have no

clearly demonstrated effect on CBF.
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7.

The posterior pituitary hormones have minimal
influence on the CBF and this is mostly dependent on their alteration of systemic blood
pressure (47).
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SUJVlMARY AND CONCLUSION
Because of importance of cerebral blood flow to
the living organism, it also becomes important to understand how this flow is maintained and altered by physiology
and rharmacology.

A discussion of the methods of stydying

this cerebral blood flow regulation is presented initially in order that current concepts might be better
uncerstood.

As these concepts are reviewed,

the most

remarkable observation is the great resistance of the
cerebrB,l blood flow to change.

There are two major fac-

tors operating in this resistance.

First, pressoreceptor

reflexes, including those with receptors in the internal
carotid artery, a

~ajor

source of supply to the brain,

operate to maintain a more or less constant blood pressure head for the cerebral circulation without involving
the cerebral vessels in the adjustments necessary to
accomplish this.

Secondly, cerebrovascular resistance

is altered by chemical products of metabolism in a manner serving to maintain hemeostasis.

The end result is

a remarkable stable blood supply to the brain which is
equally resistant to therapeutic efforts to change.
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